|
|
||||||||
Animal: RNA Viruses |
Laboratory of Virology and Chemotherapy, Rega Institute for Medical Research, Minderbroedersstraat 10, B-3000 Leuven, Belgium1
Bernhard Nocht Institute of Tropical Medicine, Hamburg, Germany2
Division of Histopathology, University Hospitals, B-3000 Leuven, Belgium3
Author for correspondence: Johan Neyts. Fax +32 16 33 73 40. e-mail johan.neyts{at}rega.kuleuven.ac.be
We have established a convenient animal model for flavivirus encephalitis using Montana Myotis leukoencephalitis virus (MMLV), a bat flavivirus. This virus has the same genomic organization, and contains the same conserved motifs in genes that encode potential antiviral targets, as flaviviruses that cause disease in man (N. Charlier et al., accompanying paper), and has a similar particle size (approximately 40 nm). MMLV replicates well in Vero cells and appears to be equally as sensitive as yellow fever virus and dengue fever virus to a selection of experimental antiviral agents. Cells infected with MMLV show dilation of the endoplasmic reticulum, a characteristic of flavivirus infection. Intraperitoneal, intranasal or direct intracerebral inoculation of SCID mice with MMLV resulted in encephalitis ultimately leading to death, whereas immunocompetent mice were refractory to either intranasal or intraperitoneal infection with MMLV. Viral RNA and/or antigens were detected in the brain and serum of MMLV-infected SCID mice, but not in any other organ examined: MMLV was detected in the olfactory lobes, the cerebral cortex, the limbic structures, the midbrain, cerebellum and medulla oblongata. Infection was confined to neurons. Treatment with the interferon-
/
inducer poly(I)·poly(C) protected SCID mice against MMLV-induced morbidity and mortality, and this protection correlated with a reduction in infectious virus titre and viral RNA load. This validates the MMLV model for use in antiviral drug studies. The MMLV SCID model may, therefore, be attractive for the study of chemoprophylactic or chemotherapeutic strategies against flavivirus infections causing encephalitis.
This article has been cited by other articles:
![]() |
C. M. P. Ribeiro, A. M. Paradiso, U. Schwab, J. Perez-Vilar, L. Jones, W. O'Neal, and R. C. Boucher Chronic Airway Infection/Inflammation Induces a Ca2+i-dependent Hyperinflammatory Response in Human Cystic Fibrosis Airway Epithelia J. Biol. Chem., May 6, 2005; 280(18): 17798 - 17806. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Leyssen, J. Balzarini, E. De Clercq, and J. Neyts The Predominant Mechanism by Which Ribavirin Exerts Its Antiviral Activity In Vitro against Flaviviruses and Paramyxoviruses Is Mediated by Inhibition of IMP Dehydrogenase J. Virol., February 1, 2005; 79(3): 1943 - 1947. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Charlier, R. Molenkamp, P. Leyssen, J. Paeshuyse, C. Drosten, M. Panning, E. De Clercq, P. J. Bredenbeek, and J. Neyts Exchanging the Yellow Fever Virus Envelope Proteins with Modoc Virus prM and E Proteins Results in a Chimeric Virus That Is Neuroinvasive in SCID Mice J. Virol., July 15, 2004; 78(14): 7418 - 7426. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Schulz, K. Mellenthin, G. Schonian, B. Fleischer, and C. Drosten Detection, Differentiation, and Quantitation of Pathogenic Leishmania Organisms by a Fluorescence Resonance Energy Transfer-Based Real-Time PCR Assay J. Clin. Microbiol., April 1, 2003; 41(4): 1529 - 1535. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Charlier, P. Leyssen, C. W. A. Pleij, P. Lemey, F. Billoir, K. Van Laethem, A.-M. Vandamme, E. De Clercq, X. de Lamballerie, and J. Neyts Complete genome sequence of Montana Myotis leukoencephalitis virus, phylogenetic analysis and comparative study of the 3' untranslated region of flaviviruses with no known vector J. Gen. Virol., August 1, 2002; 83(8): 1875 - 1885. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |